Norman C.W. Wong

Dr. Wong is Co-founder and Chief Scientific Officer of Resverlogix Corp. Dr. Wong serves as a Professor of Medicine, at the University of Calgary, a clinician and scientist who specializes in endocrinology, internal medicine, molecular biology, gene/cell therapy, and regulation. His numerous academic accomplishments include over 300 published works, including extensive research in the field of epigenetics.

Dr. Wong has served as a medical consultant to Abbott Laboratories, Amgen, Astra Zeneca, B.I., Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Sanofi, and Solvay Pharmaceuticals in the areas of diabetes mellitus, thyroid disease, testosterone treatment and in the development of cholesterol-lowering drugs. He is a Director of Zenith Epigenetics and is a member of the Scientific Advisory Board at Sernova Corp. Dr. Wong’s academic record includes an Undergraduate B.Sc., Master's Degree in medical biochemistry, and a Medical Degree from the University of Calgary.